ORGANOGENESIS HOLDINGS INC (ORGO) Fundamental Analysis & Valuation

NASDAQ:ORGO • US68621F1021

Current stock price

2.51 USD
+0.13 (+5.46%)
At close:
2.49 USD
-0.02 (-0.8%)
After Hours:

This ORGO fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. ORGO Profitability Analysis

1.1 Basic Checks

  • In the past year ORGO was profitable.
  • ORGO had a negative operating cash flow in the past year.
  • Of the past 5 years ORGO 4 years were profitable.
  • ORGO had a positive operating cash flow in 4 of the past 5 years.
ORGO Yearly Net Income VS EBIT VS OCF VS FCFORGO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M

1.2 Ratios

  • ORGO's Return On Assets of 2.65% is amongst the best of the industry. ORGO outperforms 88.76% of its industry peers.
  • Looking at the Return On Equity, with a value of 3.65%, ORGO belongs to the top of the industry, outperforming 89.92% of the companies in the same industry.
  • ORGO's Return On Invested Capital of 8.83% is amongst the best of the industry. ORGO outperforms 92.25% of its industry peers.
  • ORGO had an Average Return On Invested Capital over the past 3 years of 5.16%. This is significantly below the industry average of 27.73%.
  • The last Return On Invested Capital (8.83%) for ORGO is above the 3 year average (5.16%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 2.65%
ROE 3.65%
ROIC 8.83%
ROA(3y)1.41%
ROA(5y)5.82%
ROE(3y)2.05%
ROE(5y)10.24%
ROIC(3y)5.16%
ROIC(5y)7.22%
ORGO Yearly ROA, ROE, ROICORGO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -50 -100

1.3 Margins

  • ORGO has a Profit Margin of 2.81%. This is amongst the best in the industry. ORGO outperforms 88.57% of its industry peers.
  • In the last couple of years the Profit Margin of ORGO has declined.
  • ORGO has a Operating Margin of 9.90%. This is amongst the best in the industry. ORGO outperforms 90.31% of its industry peers.
  • In the last couple of years the Operating Margin of ORGO has grown nicely.
  • ORGO has a Gross Margin of 75.62%. This is amongst the best in the industry. ORGO outperforms 83.14% of its industry peers.
  • ORGO's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 9.9%
PM (TTM) 2.81%
GM 75.62%
OM growth 3Y26.04%
OM growth 5Y4.64%
PM growth 3Y1.07%
PM growth 5Y-6.94%
GM growth 3Y-0.48%
GM growth 5Y0.38%
ORGO Yearly Profit, Operating, Gross MarginsORGO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. ORGO Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ORGO is destroying value.
  • ORGO has more shares outstanding than it did 1 year ago.
  • ORGO has less shares outstanding than it did 5 years ago.
  • The debt/assets ratio for ORGO is higher compared to a year ago.
ORGO Yearly Shares OutstandingORGO Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
ORGO Yearly Total Debt VS Total AssetsORGO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

2.2 Solvency

  • An Altman-Z score of 2.88 indicates that ORGO is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 2.88, ORGO is in the better half of the industry, outperforming 67.44% of the companies in the same industry.
  • ORGO has a Debt/Equity ratio of 0.03. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.03, ORGO is in line with its industry, outperforming 43.41% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z 2.88
ROIC/WACC0.97
WACC9.1%
ORGO Yearly LT Debt VS Equity VS FCFORGO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M 400M

2.3 Liquidity

  • ORGO has a Current Ratio of 3.62. This indicates that ORGO is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 3.62, ORGO is in line with its industry, outperforming 44.19% of the companies in the same industry.
  • ORGO has a Quick Ratio of 3.32. This indicates that ORGO is financially healthy and has no problem in meeting its short term obligations.
  • ORGO has a Quick ratio of 3.32. This is comparable to the rest of the industry: ORGO outperforms 42.64% of its industry peers.
Industry RankSector Rank
Current Ratio 3.62
Quick Ratio 3.32
ORGO Yearly Current Assets VS Current LiabilitesORGO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. ORGO Growth Analysis

3.1 Past

  • ORGO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 52.94%, which is quite impressive.
  • The Earnings Per Share has been growing by 16.72% on average over the past years. This is quite good.
  • ORGO shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 17.04%.
  • ORGO shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.77% yearly.
EPS 1Y (TTM)52.94%
EPS 3Y25.99%
EPS 5Y16.72%
EPS Q2Q%416.67%
Revenue 1Y (TTM)17.04%
Revenue growth 3Y7.76%
Revenue growth 5Y10.77%
Sales Q2Q%78.13%

3.2 Future

  • The Earnings Per Share is expected to decrease by -5.01% on average over the next years.
  • ORGO is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -0.44% yearly.
EPS Next Y-166.69%
EPS Next 2Y-5.01%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-21.5%
Revenue Next 2Y-0.44%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ORGO Yearly Revenue VS EstimatesORGO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M 500M
ORGO Yearly EPS VS EstimatesORGO Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 0.4 -0.4 0.6

More info and screens

Find the best growth stocksShow best growing peers

4

4. ORGO Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 9.65 indicates a reasonable valuation of ORGO.
  • Based on the Price/Earnings ratio, ORGO is valued cheaper than 97.09% of the companies in the same industry.
  • ORGO is valuated cheaply when we compare the Price/Earnings ratio to 27.18, which is the current average of the S&P500 Index.
  • The Forward Price/Earnings Ratio is negative for ORGO. No positive earnings are expected for the next year.
Industry RankSector Rank
PE 9.65
Fwd PE N/A
ORGO Price Earnings VS Forward Price EarningsORGO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, ORGO is valued cheaply inside the industry as 98.45% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 3.15
ORGO Per share dataORGO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

  • The decent profitability rating of ORGO may justify a higher PE ratio.
  • ORGO's earnings are expected to decrease with -5.01% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.58
EPS Next 2Y-5.01%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ORGO Dividend Analysis

5.1 Amount

  • ORGO does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ORGO Fundamentals: All Metrics, Ratios and Statistics

ORGANOGENESIS HOLDINGS INC

NASDAQ:ORGO (4/14/2026, 4:19:05 PM)

After market: 2.49 -0.02 (-0.8%)

2.51

+0.13 (+5.46%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)02-26
Earnings (Next)05-07
Inst Owners54.55%
Inst Owner Change0.09%
Ins Owners32.5%
Ins Owner Change1.24%
Market Cap322.89M
Revenue(TTM)564.17M
Net Income(TTM)15.85M
Analysts85.71
Price Target8.16 (225.1%)
Short Float %18.99%
Short Ratio10.48
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)106.05%
Min EPS beat(2)44.72%
Max EPS beat(2)167.38%
EPS beat(4)2
Avg EPS beat(4)16.53%
Min EPS beat(4)-73%
Max EPS beat(4)167.38%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)19.19%
Min Revenue beat(2)10.3%
Max Revenue beat(2)28.08%
Revenue beat(4)2
Avg Revenue beat(4)6.94%
Min Revenue beat(4)-6.36%
Max Revenue beat(4)28.08%
Revenue beat(8)6
Avg Revenue beat(8)7.04%
Revenue beat(12)7
Avg Revenue beat(12)4.32%
Revenue beat(16)7
Avg Revenue beat(16)2.3%
PT rev (1m)-5.88%
PT rev (3m)-5.88%
EPS NQ rev (1m)6.45%
EPS NQ rev (3m)-222.22%
EPS NY rev (1m)-580%
EPS NY rev (3m)-217.24%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-56.57%
Revenue NY rev (1m)-14.36%
Revenue NY rev (3m)-26.17%
Valuation
Industry RankSector Rank
PE 9.65
Fwd PE N/A
P/S 0.57
P/FCF N/A
P/OCF N/A
P/B 0.74
P/tB 0.82
EV/EBITDA 3.15
EPS(TTM)0.26
EY10.36%
EPS(NY)-0.17
Fwd EYN/A
FCF(TTM)-0.19
FCFYN/A
OCF(TTM)-0.08
OCFYN/A
SpS4.39
BVpS3.37
TBVpS3.08
PEG (NY)N/A
PEG (5Y)0.58
Graham Number4.44
Profitability
Industry RankSector Rank
ROA 2.65%
ROE 3.65%
ROCE 11.21%
ROIC 8.83%
ROICexc 10.88%
ROICexgc 12%
OM 9.9%
PM (TTM) 2.81%
GM 75.62%
FCFM N/A
ROA(3y)1.41%
ROA(5y)5.82%
ROE(3y)2.05%
ROE(5y)10.24%
ROIC(3y)5.16%
ROIC(5y)7.22%
ROICexc(3y)6.81%
ROICexc(5y)10.02%
ROICexgc(3y)7.75%
ROICexgc(5y)12.19%
ROCE(3y)6.54%
ROCE(5y)9.15%
ROICexgc growth 3Y14.91%
ROICexgc growth 5Y-14%
ROICexc growth 3Y18.93%
ROICexc growth 5Y-6.02%
OM growth 3Y26.04%
OM growth 5Y4.64%
PM growth 3Y1.07%
PM growth 5Y-6.94%
GM growth 3Y-0.48%
GM growth 5Y0.38%
F-Score2
Asset Turnover0.94
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA 0.17
Cap/Depr 76.1%
Cap/Sales 2.51%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.62
Quick Ratio 3.32
Altman-Z 2.88
F-Score2
WACC9.1%
ROIC/WACC0.97
Cap/Depr(3y)97.86%
Cap/Depr(5y)180.1%
Cap/Sales(3y)3.4%
Cap/Sales(5y)4.88%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)52.94%
EPS 3Y25.99%
EPS 5Y16.72%
EPS Q2Q%416.67%
EPS Next Y-166.69%
EPS Next 2Y-5.01%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)17.04%
Revenue growth 3Y7.76%
Revenue growth 5Y10.77%
Sales Q2Q%78.13%
Revenue Next Year-21.5%
Revenue Next 2Y-0.44%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y159.64%
EBIT growth 3Y35.82%
EBIT growth 5Y15.91%
EBIT Next Year-3.85%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-685.73%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-172.56%
OCF growth 3YN/A
OCF growth 5YN/A

ORGANOGENESIS HOLDINGS INC / ORGO Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for ORGANOGENESIS HOLDINGS INC?

ChartMill assigns a fundamental rating of 5 / 10 to ORGO.


What is the valuation status of ORGANOGENESIS HOLDINGS INC (ORGO) stock?

ChartMill assigns a valuation rating of 4 / 10 to ORGANOGENESIS HOLDINGS INC (ORGO). This can be considered as Fairly Valued.


Can you provide the profitability details for ORGANOGENESIS HOLDINGS INC?

ORGANOGENESIS HOLDINGS INC (ORGO) has a profitability rating of 7 / 10.


Can you provide the financial health for ORGO stock?

The financial health rating of ORGANOGENESIS HOLDINGS INC (ORGO) is 4 / 10.


What is the earnings growth outlook for ORGANOGENESIS HOLDINGS INC?

The Earnings per Share (EPS) of ORGANOGENESIS HOLDINGS INC (ORGO) is expected to decline by -166.69% in the next year.